Abstract:Aim. Despite scientific and clinical success, glioblastoma remains the most aggressive tumor of the brain with extremely low prognostic potential for the patient. Biomarkers determining prognosis, and hence a treatment strategy, remains an actual problem at the moment. miRNAs can be considered as markers of glioblastoma. World’s long-term study confirm the legitimacy of miRNAs usage as reliable markers for the tumors diagnosis and prognosis, in particular brain tumors. The purpose of our study was miRNAs targe… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.